Journal profile · Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
European Pharmaceutical Journal
ISSN 2453-6725 · Walter de Gruyter · Poland
European Pharmaceutical Journal: diamond open access (no APC); no APC; review about 21 weeks (community reports); 13 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
European Pharmaceutical Journal is published by Walter de Gruyter. By OpenAlex counts of its recent articles, its largest topics are Advanced Drug Delivery Systems, Analytical Methods in Pharmaceuticals and Drug Solubulity and Delivery Systems, together about 22.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The aim of the journal is to present Central European (especially Slovak) and international scientific achievements in pharmaceutical sciences. The journal publishes research articles, short communications, and review articles on all aspects of the pharmaceutical sciences including:• Pharmacology, toxicology, clinical pharmacy• Anorganic, organic, physical, analytical, and pharmaceutical chemistry• Biochemistry• Pharmacognosy and natural medicines• Pharmaceutical technology• Pharmaceutical care• Regulatory scienceThe strong emphasis is given on quality and originality of the manuscripts. Submission of materials generated by AI is discouraged.Review articles are only by invitation or by consent of the Editors. Proceedings of scientific meetings may be published as Special issues upon discussions with the Editor/Publisher.
From the journal's Aims & Scope
Research area (LetPub): Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
Editor-in-chief Juraj PiešťanskýPublisher website
Editorial board by country: none in mainland China; most named Czechia 4, Germany 2, Italy 2, United States 1, Spain 1 (15 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics8.6%
- Analytical Methods in PharmaceuticalsChemistry7%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics6.7%
- Medicinal Plant ResearchAgricultural and Biological Sciences6.7%
- Surfactants and Colloidal SystemsChemistry6.4%
- Pharmacy and Medical PracticesPharmacology, Toxicology and Pharmaceutics6.4%
- Phytochemicals and Antioxidant ActivitiesMedicine4.5%
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| General Pharmacology, Toxicology and Pharmaceutics | Q4 | 69/79 | 13th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.6LetPub ·
- CiteScore (publisher)
- 0.6Publisher website ·
- SJR 2026-06
- 0.15LetPub ·
- SNIP 2026-06
- 0.09LetPub ·
- h-index
- 9OpenAlex ·
- i10-index
- 6OpenAlex ·
- 2-year mean citedness
- 0.33OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 278 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 8 | 8 | 49 |
| 2025 | 13 | 13 | 78 |
| 2024 | 12 | 12 | 71 |
| 2023 | 23 | 23 | 83 |
| 2022 | 18 | 18 | 63 |
| 2021 | 27 | 27 | 67 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 21 weeksLetPub ·
- Submission to publication (journal-reported)
- about 21 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC-ND | |
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteLicense & copyright
- License & copyright Copyright 2026 © Paradigm. All rights reserved.
Currency:EUR €USD $GBP £ Terms of servicePrivacy policyEthical policiesAccessibility
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Walter de Gruyter
- Country or region
- Poland
- Language
- English
- ISSN
- 2453-6725
- Print ISSN
- 0301-2298
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about European Pharmaceutical Journal
How long does peer review take at European Pharmaceutical Journal?
Authors report an average review time of about 21 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of European Pharmaceutical Journal based?
Of the 15 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Czechia (4), Germany (2) and Italy (2). Counted from the institutions listed on the board page; for reference only.
Which databases index European Pharmaceutical Journal?
According to LetPub and DOAJ records, European Pharmaceutical Journal is indexed in Scopus and DOAJ.
Is European Pharmaceutical Journal open access, and what is the APC?
European Pharmaceutical Journal is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .